Stelara(Ustekinumab)
Medicare prescription drug cost, prescriptions and prescribers, 2024
$3.38B
Medicare cost, 2024
$3.38B
Medicare cost, 2024
Medicare drug plans spent $3.4 billion on Stelara (ustekinumab) in 2024, for 132,814 prescriptions and refills filled by 24,746 patients. It ranks 15th among all drugs by Medicare drug plan spending. At about $25,424 per prescription it is a high-cost drug. California accounts for the most spending ($246.6 million, 7% of the total).
Medicare cost, 2024
$3.38B
+13.1% from 2023
Prescriptions
133K
$25,424.15 per claim
Patients
25K
14,474 prescribers
Total spending
-
All plans
Questions and answers
How much does Medicare spend on Stelara?
Medicare prescription drug plans paid $3.38B for Stelara in 2024, for 132,814 prescriptions and refills to 24,746 patients (up 13.1% from 2023). The average cost per claim was $25,424.15.
Which state spends the most on Stelara?
California had the highest Medicare cost for Stelara in 2024: $246.6M for 10,685 claims, followed by New York ($243.3M).
Who prescribes Stelara the most?
Maranda Dillon, nurse practitioner in Flowood, MS, had the highest Medicare cost for Stelara in 2024: 656 claims costing $18.0M.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Stelara, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Maranda Dillon Flowood, MS | Nurse Practitioner | 656 | 100 | $18.0M |
| Donna P Ortiz Orlando, FL | Nurse Practitioner | 458 | 56 | $12.7M |
| Vanessa Mendez Hialeah, FL | Gastroenterology | 294 | 54 | $7.8M |
| Udayakumar Navaneethan Saint Petersburg, FL | Gastroenterology | 265 | 34 | $7.1M |
| Nitin Gupta Atlanta, GA | Gastroenterology | 245 | 43 | $6.7M |
| Douglas C Wolf Atlanta, GA | Gastroenterology | 241 | 32 | $6.6M |
| Elizabeth Harding Charleston, SC | Physician Assistant | 202 | 41 | $6.6M |
| Jason N Schairer Novi, MI | Gastroenterology | 253 | 34 | $6.5M |
| Parakkal Deepak Saint Louis, MO | Gastroenterology | 219 | 27 | $6.1M |
| Megan M Pearce Orlando, FL | Nurse Practitioner | 221 | 40 | $5.9M |
| Andrea Banty West Hollywood, CA | Nurse Practitioner | 203 | 32 | $5.7M |
| Alison P Kerekes Durham, NC | Physician Assistant | 214 | 35 | $5.5M |
| David P Hudesman New York, NY | Gastroenterology | 207 | 23 | $5.5M |
| Esther A Torres San Juan, PR | Gastroenterology | 194 | 34 | $5.3M |
| Matthew D McCoy Jackson, MS | Physician Assistant | 192 | 26 | $5.3M |
| Ellen J Scherl New York, NY | Gastroenterology | 187 | 28 | $5.2M |
| Vicki E Allen Charleston, SC | Physician Assistant | 158 | 31 | $5.1M |
| Amy Stuffelbeam Lexington, KY | Physician Assistant | 189 | 26 | $4.9M |
| Richard P Rood Saint Louis, MO | Gastroenterology | 176 | 26 | $4.9M |
| Heba N Iskandar Atlanta, GA | Gastroenterology | 179 | 24 | $4.9M |
| Joseph Feuerstein Boston, MA | Gastroenterology | 178 | 23 | $4.8M |
| Libby Wolf Palo Alto, CA | Nurse Practitioner | 154 | 20 | $4.8M |
| Mark G Lazarev Baltimore, MD | Gastroenterology | 164 | 22 | $4.8M |
| Erin M Forster Charleston, SC | Gastroenterology | 130 | 27 | $4.8M |
| Jean-Paul Achkar Cleveland, OH | Gastroenterology | 169 | 27 | $4.8M |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 12,308 | 96,952 | 19,964 | $2.34B |
| 2023 | 13,395 | 117,028 | 22,920 | $2.99B |
| 2024 | 14,474 | 132,814 | 24,746 | $3.38B |
Medicaid spending by quarter
Amount reimbursed by state Medicaid programs, all states
Amount reimbursed
Codes
- National drug codes (packages)
- 7
- RxNorm concept IDs
- 1654077, 1654079, 1811255, 1811257, 853350
- Application numbers
- BLA125261, BLA761044
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through September 2026, 103,830 side-effect reports named ustekinumab, the active ingredient of Stelara (reports from 2009 on). 62,003 of them (59.7%) were serious, 6,235 named a death and 22,914 named a hospital stay. The reactions named most often were drug ineffective, off label use and product dose omission issue. 41,099 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
103,830
7,487 in 2025 (-19.0% from 2024)
Serious
59.7%
62,003 reports
Deaths named
6,235
6.0% of reports
Hospital stays
22,914
22.1% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Stelara?
103,830 reports from 2009 through September 2026 named ustekinumab, the active ingredient of Stelara. 62,003 of them (59.7%) were serious, 6,235 named a death and 22,914 named a hospital stay.
What are the most reported side effects of Stelara?
14,979 reports named drug ineffective, the reaction named most often, followed by off label use (12,938) and product dose omission issue (10,264). In the last 5 years the reaction named most often was product dose omission issue (8,017 reports). A report can name several reactions.
How many side-effect reports named Stelara in 2025?
7,487 reports were received in 2025 (-19.0% from 2024). 2026 so far: 4,434 reports through September 2026, and more keep arriving late.
Do side-effect reports prove that Stelara caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Stelara caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Other Medicare drug pages with ustekinumab: Stelara*
- Makers on the stock market:
JNJ·JNJ drug pipeline - Drug approvals (2 approvals on file for ustekinumab) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (ustekinumab) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.